CHUNG, HoYeon

Position : Professor Department of Medicine, Division of Endocrinology and Metabolism

Specialty :

  • Osteoporosis, thyroid, diabetes, adrenal, endocrine disorders

Education :

  • Kyung Hee University, College of Medicine, Seoul, Korea (M.D)
  • Depart. Of internal medicine, Kynng-Hee University, College of Medicine, Seoul, Korea(M.S)
  • Depart. Of endocrinology & metabolism, Kynng-Hee University, College of Medicine, Seoul, Korea(PhD.)

Experience & Society Memberships :

  • Resident , Kyung Hee University Medical Center
  • University of Texas at San Antonio(Postdoctoral fellowship)
  • University of Pittsburgh(Research associate)
  • Professor, Sungkyunkwan University Samsung Cheil Hospital
  • Director of Endocrine Metabolism Center, Kyung Hee University Hospital at Gang Dong, Seoul, Korea
  • Нospital director, Kyung Hee University Hospital at Gang Dong, Seoul, Korea
  • Secretary of education committee of The Korean Society of Internal Medicine
  • Director of Korean Endocrinology Society
  • President of Bone Metabolic disease committee of Korean Endocrinology Society
  • Director of Korean Bone Metabolic disease Society
  • Member of Korean Diabetes Association
  • Member of Korean Society of Obesity
  • Member of The Korean Society of Postmenopause

Research papers/  Book chapters:

  • Differential association between sarcopenia and metabolic phenotype in Korean young and older adults with and without obesity (OBESITY. 2017;25(1):244-251) middle east respiratory syndrome coronavirus transmission in dialysis unit and infection control interventions in Korea (INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY. 2016;37(12):1514-1516)
  • Aster spathulifolius maxim extract reduces body weight and fat mass in obese humans (NUTRITION RESEARCH. 2016;36(0):671-678)
  • The pharmacological stimulation of Nurr1 improves cognitive functions via enhancement of adult hippocampal neurogenesis (STEM CELL RESEARCH. 2016;17(3):534-543) effects of c-reactive protein on bone cells (LIFE SCIENCES. 2016;145(0):1-8)
  • Efficacay of a once-monthly pill containing ibandronate and cholecalciferol on the levels of 25-hydroxyvitamin D and bone markers in postmenopausal woment with osteoporosis (Endocrinology and Metabolism. 2015;30(3):272-279) association between the circulating total osteocalcin level and the development of cardiovascular disease in middle-aged men: a mean 8.7-year longitudinal follow-up study (JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. 2015;22(2):136-143)
  • calcium and vitamin D supplementations:2015 position statement of the korean society for bone and mineral research. 2015;22
  • acromegaly with normal insulin like growth factor-1 levels and congestive heart failure as the first clincal manifestation (Endocrinology and Metabolism. 2015;30(3):395-401)
  • Changes in serum osteocalcin are not associated with changes in glucose or insulin for osteoporotic patients treated with bisphosphonate (대한골대사학회지. 2013;20(1):37-41)
  • optimal serum concentration of hydroxyvitamin D for bone health in older korean adults (CALCIFIED TISSUE INTERNATIONAL. 2013;92(0):68-74)
  • Early changes in 25-hydroxyvitamin D levels and bone markers after monthly risedronate with cholecalciferol in Korean patients with osteoporosis (CLINICAL INTERVENTIONS IN AGING. 2013;8(0):597-603)
  • risk factors for the progression fo intima-media thickness of carotid arteries: a 2-year follow-up study in patient with newly diagnosed type 2 diabetes (KOREAN DIABETES JOURNAL(당뇨병). 2013;37(0):365-374)
  • bisphenol A reduces differentiation and stimulates apoptosis of osteoclasts and osteoblasts (LIFE SCIENCES. 2013;93(0):367-372)
  • sarcopenia is independently associated with cardiovascular disease in older Korean adults: the korea national health and nutrition examination survey from 2009 (PLOS ONE. 2013;8(3):e60119-e60119)
  • validation of a new food frequency questionnaire for assessment of calcium and vitamin D intake in Korean women (2013;20(2):67-74)
  • etc.